Skip to main content
Erschienen in: European Journal of Pediatrics 10/2013

01.10.2013 | Case Report

Refractory congestive heart failure following delayed pericardectomy in a 12-year-old child with Mulibrey nanism due to a novel mutation in TRIM37

verfasst von: Matthias Kumpf, Riikka H. Hämäläinen, Michael Hofbeck, Winfried Baden

Erschienen in: European Journal of Pediatrics | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Mulibrey nanism (MUL) is a rare autosomal recessive disorder with severe primordial growth retardation and multiorgan involvement, caused by mutations in TRIM37. Early clinical detection is important since more than 50 % of the patients develop congestive heart failure. We report a 12-year-old patient who presented in infancy with severe growth retardation, dysmorphic features, and cleft palate. Clinical diagnosis of MUL was established at the age of 5 years. Postmortem, molecular diagnostic confirmed MUL as a novel 1-bp deletion (c.1233delA) in exon 14 of the TRIM37 coding region. Cardiac examination at the age of 6 years revealed constrictive pericarditis with significant elevation of atrial filling pressures, consecutive hepatomegaly, and protein loosing enteropathy. Since the parents refused pericardectomy, surgery was delayed until the age of 12 years, when congestive heart failure deteriorated. Despite pericardectomy, the boy died from persistent right heart failure. Conclusion: Our report underlines the necessity of early clinical diagnosis of Mulibrey nanism. Careful cardiologic examination is required to detect constrictive pericarditis, which is a major factor of mortality in these patients. Pericardectomy should be performed early, to avoid sequelae of persisting congestive heart failure.
Literatur
1.
Zurück zum Zitat Avela K, Lipsanen-Nyman M, Idänheimo N, Seemanová E, Rosengren S, Mäkelä TP, Perheentupa J, Chapelle AD, Lehesjoki AE (2000) Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism. Nat Genet 25:298–301PubMedCrossRef Avela K, Lipsanen-Nyman M, Idänheimo N, Seemanová E, Rosengren S, Mäkelä TP, Perheentupa J, Chapelle AD, Lehesjoki AE (2000) Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism. Nat Genet 25:298–301PubMedCrossRef
2.
Zurück zum Zitat Clayton PE, Hanson D, Magee L, Murray PG, Saunders E, Abu-Amero SN, Moore GE, Black GC (2012) Exploring the spectrum of 3-M syndrome, a primordial short stature disorder of disrupted ubiquitination. Clin Endocrinol (Oxf) 77:335–342CrossRef Clayton PE, Hanson D, Magee L, Murray PG, Saunders E, Abu-Amero SN, Moore GE, Black GC (2012) Exploring the spectrum of 3-M syndrome, a primordial short stature disorder of disrupted ubiquitination. Clin Endocrinol (Oxf) 77:335–342CrossRef
3.
Zurück zum Zitat Eerola A, Pihkala JI, Karlberg N, Lipsanen-Nyman M, Jokinen E (2007) Cardiac dysfunction in children with mulibrey nanism. Pediatr Cardiol 28:155–162PubMedCrossRef Eerola A, Pihkala JI, Karlberg N, Lipsanen-Nyman M, Jokinen E (2007) Cardiac dysfunction in children with mulibrey nanism. Pediatr Cardiol 28:155–162PubMedCrossRef
4.
Zurück zum Zitat Kallijärvi J, Avela K, Lipsanen-Nyman M, Ulmanen I, Lehesjoki AE (2003) The TRIM37 gene encodes a peroxisomal RING-B-box-coiled-coil protein: classification of mulibrey nanism as a new peroxisomal disorder. Am J Hum Genet 70:1215–1228CrossRef Kallijärvi J, Avela K, Lipsanen-Nyman M, Ulmanen I, Lehesjoki AE (2003) The TRIM37 gene encodes a peroxisomal RING-B-box-coiled-coil protein: classification of mulibrey nanism as a new peroxisomal disorder. Am J Hum Genet 70:1215–1228CrossRef
5.
Zurück zum Zitat Karlberg N, Jalanko H, Lipsanen-Nyman M (2007) Growth and growth hormone therapy in subjects with mulibrey nanism. Pediatrics 120:e102–e111PubMedCrossRef Karlberg N, Jalanko H, Lipsanen-Nyman M (2007) Growth and growth hormone therapy in subjects with mulibrey nanism. Pediatrics 120:e102–e111PubMedCrossRef
6.
Zurück zum Zitat Karlberg N, Jalanko H, Perheentupa J, Lipsanen-Nyman M (2004) Mulibrey nanism: clinical features and diagnostic criteria. J Med Genet 41:92–98PubMedCrossRef Karlberg N, Jalanko H, Perheentupa J, Lipsanen-Nyman M (2004) Mulibrey nanism: clinical features and diagnostic criteria. J Med Genet 41:92–98PubMedCrossRef
7.
Zurück zum Zitat Karlberg N, Karlberg S, Karikoski R, Mikkola S, Lipsanen-Nyman M, Jalanko H (2009) High frequency of tumours in Mulibrey nanism. J Pathol 218:163–171PubMedCrossRef Karlberg N, Karlberg S, Karikoski R, Mikkola S, Lipsanen-Nyman M, Jalanko H (2009) High frequency of tumours in Mulibrey nanism. J Pathol 218:163–171PubMedCrossRef
8.
Zurück zum Zitat Karlberg S, Toppari J, Karlberg N, Nurmio M, Karikoski R, Jalanko H, Lipsanen-Nyman M (2011) Testicular failure and male infertility in the monogenic Mulibrey nanism disorder. J Clin Endocrinol Metab 9:3399–40CrossRef Karlberg S, Toppari J, Karlberg N, Nurmio M, Karikoski R, Jalanko H, Lipsanen-Nyman M (2011) Testicular failure and male infertility in the monogenic Mulibrey nanism disorder. J Clin Endocrinol Metab 9:3399–40CrossRef
9.
Zurück zum Zitat Kivisto S, Lipsanen-Nyman M, Kupari M, Hekali P, Lauerma K (2004) Cardiac involvement in Mulibrey nanism: characterization with magnetic resonance imaging. J Cardiovasc Magn Reson 6:645–652PubMedCrossRef Kivisto S, Lipsanen-Nyman M, Kupari M, Hekali P, Lauerma K (2004) Cardiac involvement in Mulibrey nanism: characterization with magnetic resonance imaging. J Cardiovasc Magn Reson 6:645–652PubMedCrossRef
10.
Zurück zum Zitat Kokki S, Lauerma K, Kupari M, Lipsanen-Nyman M, Hekali P (2000) Assessment of mulibrey nanism cardiopathy with functional magnetic resonance imaging. MAGMA 11:84–86PubMed Kokki S, Lauerma K, Kupari M, Lipsanen-Nyman M, Hekali P (2000) Assessment of mulibrey nanism cardiopathy with functional magnetic resonance imaging. MAGMA 11:84–86PubMed
11.
Zurück zum Zitat Lipsanen-Nyman M, Perheentupa J, Rapola J, Sovijarvi A, Kupari M (2003) Mulibrey heart disease: clinical manifestations, long-term course, and results of pericardiectomy in a series of 49 patients born before 1985. Circulation 107:2810–2815PubMedCrossRef Lipsanen-Nyman M, Perheentupa J, Rapola J, Sovijarvi A, Kupari M (2003) Mulibrey heart disease: clinical manifestations, long-term course, and results of pericardiectomy in a series of 49 patients born before 1985. Circulation 107:2810–2815PubMedCrossRef
12.
Zurück zum Zitat Prader A, Largo RH, Molinari L, Issler C (1989) Physical growth of Swiss children from birth to 20 years of age. First Zürich longitudinal study of growth and development. Helv Paediatr Acta Suppl 52:1–125 Prader A, Largo RH, Molinari L, Issler C (1989) Physical growth of Swiss children from birth to 20 years of age. First Zürich longitudinal study of growth and development. Helv Paediatr Acta Suppl 52:1–125
13.
Zurück zum Zitat Wollmann HA, Kirchner T, Enders H, Preece MA, Ranke MB (1995) Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr 154:958–968PubMedCrossRef Wollmann HA, Kirchner T, Enders H, Preece MA, Ranke MB (1995) Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr 154:958–968PubMedCrossRef
Metadaten
Titel
Refractory congestive heart failure following delayed pericardectomy in a 12-year-old child with Mulibrey nanism due to a novel mutation in TRIM37
verfasst von
Matthias Kumpf
Riikka H. Hämäläinen
Michael Hofbeck
Winfried Baden
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 10/2013
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-013-1962-2

Weitere Artikel der Ausgabe 10/2013

European Journal of Pediatrics 10/2013 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.